Dr. Mekhail Anwar's lab at UCSF focuses on improving cancer treatment through advanced imaging techniques. By developing non-invasive imaging methods, the lab aims to detect and monitor how patients respond to immunotherapies, which can help identify when treatments are not effective. The lab also works on innovative optical imaging technologies to ensure that cancer cells are not left behind during surgeries, aiming to improve patient outcomes.

Dr. Mary Helen Barcellos-Hoff's research lab focuses on innovative treatments for cancer using radiopharmaceutical therapy (RPT). By targeting transforming growth factor (TGF) activity, which is often dysregulated in cancer, her team aims to develop new theranostic approaches that can be applied across various types of tumors. Through preclinical cancer models, they investigate how RPT can be optimized for better efficacy and understanding of biological responses to radiation treatment.

Dr. Steven Hetts' lab is focused on developing innovative devices to improve cancer treatment by minimizing the systemic side effects of chemotherapy. They create specialized filters that can remove chemotherapy drugs from the bloodstream after they have targeted tumors, helping to reduce overall toxicity. The lab works on modeling, testing, and optimizing these devices to make cancer treatments more effective and safer for patients.

Dr. Peder Eric Zufall Larson’s lab focuses on using advanced magnetic resonance imaging (MRI) techniques to understand heart disease, particularly how changes in heart metabolism can influence various heart conditions. By developing a specialized method called hyperpolarized 13C MRI, the lab aims to investigate metabolic remodeling in patients with hypertrophic cardiomyopathy, a common inherited heart condition. Their work has implications for better diagnosis and management of heart diseases through improved imaging processes.

Dr. Youngho Seo's lab focuses on developing advanced imaging techniques to detect early signs of heart damage in cancer patients undergoing treatment. The research particularly investigates how to monitor the cardiovascular effects of various cancer therapies, including traditional chemotherapy and newer immunotherapy approaches, using a specialized PET imaging agent. The goal is to enhance patient care by enabling timely interventions that mitigate heart-related risks associated with cancer treatments.

Dr. Yan Li's lab at the University of California, San Francisco focuses on understanding and improving cognitive functioning and quality of life for patients with lower grade astrocytoma. They use advanced MRI techniques to assess how tumors and their treatment impact brain function. The research aims to develop better clinical strategies for patient management and treatment therapy based on their findings.

Dr. Duan Xu's lab focuses on improving MRI techniques to evaluate glioma patients, who have the most common type of brain tumor. The lab aims to develop new tools and software that make it easier to interpret MR images and track the progression of tumors over time. By integrating metabolic imaging and enhancing the imaging workflow, the lab works to provide clearer insights into tumor behavior and treatment response, ultimately aiming to improve patient outcomes.

Dr. Bruce Faddegon's lab at UCSF focuses on improving cancer treatment techniques using particle therapy, which includes protons and carbon ions. They aim to develop more precise treatment planning methods based on a detailed understanding of ionization patterns produced by these therapies. By integrating new prediction models, the lab hopes to enhance the effectiveness of radiation therapy while minimizing damage to healthy tissue, ultimately improving outcomes for cancer patients.

Dr. Robert Flavell's lab focuses on developing innovative therapies for cancers, specifically targeting CD46 in multiple myeloma and prostate cancer. The research aims to optimize radioimmunotherapy methods that minimize side effects while effectively treating tumors. The lab combines various scientific disciplines, including chemistry, biology, and imaging, to advance cancer treatment strategies and enhance diagnostic methods.

Dr. Galateia J Kazakia's research lab focuses on understanding bone health in patients with chronic kidney disease (CKD) and those recovering from fractures. The lab is exploring innovative, non-invasive methods to assess bone turnover, which is critical for managing fracture risk. By using advanced imaging techniques, the lab aims to improve patient care and develop strategies to prevent fractures, especially in older patients.

Dr. Olivier Morin's lab focuses on improving treatment strategies for brain metastases in patients with non-small cell lung cancer. They are developing a personalized approach to predict brain metastases using advanced MRI techniques, aiming to minimize radiation exposure to healthy brain tissue. This research combines data from many patients to create a tailored treatment that can enhance patient survival and quality of life while reducing side effects from radiation therapy.

Dr. Melanie A Morrison's lab focuses on enhancing the success of deep brain stimulation (DBS) for Parkinson's disease patients. They are developing advanced MRI techniques to reliably predict how well patients will respond to DBS. By using a combination of different MRI imaging modalities, they aim to better inform doctors on which patients are the best candidates for this therapy, ultimately leading to improved outcomes and reduced risks of side effects.

Dr. Yi Li's lab focuses on understanding brain injuries in newborns who suffer from a lack of oxygen at birth. They use advanced MRI techniques to study how different types of brain damage affect motor skills and language development in infants. The lab aims to improve diagnosis and treatment for these infants by developing better ways to predict their developmental outcomes based on MRI findings.

Wensha Yang's lab focuses on improving radiation therapy for liver tumors by combining advanced imaging techniques with treatment planning strategies. They aim to minimize damage to healthy liver tissue while effectively targeting tumors, thereby reducing complications such as radiation-induced liver disease. Their innovative approach includes a novel MR imaging technique and optimizing treatment plans to enhance patient outcomes.

Dr. David Raleigh's lab at UCSF focuses on understanding and treating meningiomas, a type of brain tumor. The lab studies the genetic mechanisms that cause these tumors and aims to develop better treatments using innovative models. By using human samples and advanced techniques like organoids and CRISPR, they hope to improve outcomes for patients with meningiomas.

Dr. Thomas Link's lab at UCSF focuses on understanding how changes in body weight influence the progression of knee osteoarthritis (OA), particularly in overweight and obese individuals. The research aims to uncover the biological mechanisms behind this relationship, such as inflammation and muscle health, to develop personalized treatment strategies. By analyzing large datasets and utilizing advanced machine learning techniques, the lab hopes to create prediction models that can tailor interventions to patients, ultimately improving outcomes and preventing severe joint issues.

Dr. Michael John Evans' lab focuses on developing new radiotherapy strategies to treat prostate cancer by utilizing the unique biochemistry of human kallikrein 2 (hK2). The lab is pioneering novel low molecular weight peptides that can target cancer cells more effectively and safely, offering enhanced therapeutic benefits over current treatments. This research aims not only to improve tumor imaging and assessment but also to create targeted radiopharmaceuticals that can better deliver radiation directly to cancer cells while minimizing side effects.

Dr. David M. Wilson's lab at UCSF focuses on developing advanced imaging techniques to enhance our understanding and diagnosis of Alzheimer's disease and other conditions. They work on creating new PET imaging tracers that can help visualize changes in brain cells associated with Alzheimer’s, as well as tracers designed to detect bacterial infections more effectively. Their research aims to bridge the gap between innovative tracer synthesis and real-world clinical applications, benefiting patients with neurological and infectious diseases.

Dr. Sharmila Majumdar's lab at UCSF focuses on understanding osteoarthritis (OA), a painful joint condition that affects millions. The lab employs advanced imaging and biomechanics techniques to track and analyze joint health over time, aiming to improve early diagnosis and intervention strategies. By studying how joint degeneration progresses, they hope to develop better preventive treatments for OA, particularly targeting those at high risk.

Dr. Henry Vanbrocklin's lab focuses on creating innovative ways to improve prostate cancer treatment using nanomedicines. They are developing a special type of drug that carries a PARP inhibitor to tumors more effectively and is linked with a molecular imaging tool to track its delivery. Their approach aims to enhance the effectiveness of prostate cancer therapies while minimizing side effects, potentially changing how patients are treated in the future.